A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Status:
Active, not recruiting
Trial end date:
2021-10-06
Target enrollment:
Participant gender:
Summary
The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in
combination with chemotherapy in participants with advanced/metastatic solid tumors.